As Google joins Apple in adding heart rhythm sensors to wearable devices, and millions of people gain access to alerts that flag when their hearts might have skipped a beat, cardiologists are wondering what to do with all the information.
There’s still not enough evidence to truly assess the pros and cons of general screening for atrial fibrillation (AFib), according to the U.S. Preventive.